CN110963902A - Method for synthesizing R-citronellal by water-oil two-phase asymmetric hydrogenation and catalyst used in method - Google Patents
Method for synthesizing R-citronellal by water-oil two-phase asymmetric hydrogenation and catalyst used in method Download PDFInfo
- Publication number
- CN110963902A CN110963902A CN201911237004.0A CN201911237004A CN110963902A CN 110963902 A CN110963902 A CN 110963902A CN 201911237004 A CN201911237004 A CN 201911237004A CN 110963902 A CN110963902 A CN 110963902A
- Authority
- CN
- China
- Prior art keywords
- water
- catalyst
- metal precursor
- citronellal
- ligands
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003054 catalyst Substances 0.000 title claims abstract description 70
- 238000000034 method Methods 0.000 title claims abstract description 27
- 238000009876 asymmetric hydrogenation reaction Methods 0.000 title claims abstract description 21
- 230000002194 synthesizing effect Effects 0.000 title abstract description 8
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 claims abstract description 108
- 239000003446 ligand Substances 0.000 claims abstract description 63
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 claims abstract description 59
- WTEVQBCEXWBHNA-YFHOEESVSA-N citral B Natural products CC(C)=CCC\C(C)=C/C=O WTEVQBCEXWBHNA-YFHOEESVSA-N 0.000 claims abstract description 37
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 32
- 239000001257 hydrogen Substances 0.000 claims abstract description 32
- 238000006243 chemical reaction Methods 0.000 claims abstract description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 26
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 21
- 241000134874 Geraniales Species 0.000 claims abstract description 16
- 229910003002 lithium salt Inorganic materials 0.000 claims abstract description 16
- 159000000002 lithium salts Chemical class 0.000 claims abstract description 16
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 claims abstract description 8
- 150000004696 coordination complex Chemical class 0.000 claims abstract description 7
- 238000005191 phase separation Methods 0.000 claims abstract description 4
- 239000003638 chemical reducing agent Substances 0.000 claims abstract description 3
- 229910052751 metal Inorganic materials 0.000 claims description 63
- 239000002184 metal Substances 0.000 claims description 63
- NEHNMFOYXAPHSD-UHFFFAOYSA-N citronellal Chemical compound O=CCC(C)CCC=C(C)C NEHNMFOYXAPHSD-UHFFFAOYSA-N 0.000 claims description 60
- 239000002243 precursor Substances 0.000 claims description 49
- 239000010948 rhodium Substances 0.000 claims description 38
- 229910052708 sodium Inorganic materials 0.000 claims description 28
- 239000011734 sodium Substances 0.000 claims description 28
- 229930003633 citronellal Natural products 0.000 claims description 26
- 235000000983 citronellal Nutrition 0.000 claims description 26
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 22
- -1 (2-amino-1, 2-diphenylethyl) sulfamoyl Chemical group 0.000 claims description 21
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 20
- 229910052703 rhodium Inorganic materials 0.000 claims description 16
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 claims description 15
- 229940077388 benzenesulfonate Drugs 0.000 claims description 12
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 claims description 12
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 claims description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 11
- CUJRVFIICFDLGR-UHFFFAOYSA-N acetylacetonate Chemical compound CC(=O)[CH-]C(C)=O CUJRVFIICFDLGR-UHFFFAOYSA-N 0.000 claims description 11
- 229910002091 carbon monoxide Inorganic materials 0.000 claims description 11
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 11
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- 239000000460 chlorine Substances 0.000 claims description 9
- DNZZPKYSGRTNGK-PQZOIKATSA-N (1z,4z)-cycloocta-1,4-diene Chemical compound C1C\C=C/C\C=C/C1 DNZZPKYSGRTNGK-PQZOIKATSA-N 0.000 claims description 8
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 8
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims description 8
- SJYNFBVQFBRSIB-UHFFFAOYSA-N norbornadiene Chemical compound C1=CC2C=CC1C2 SJYNFBVQFBRSIB-UHFFFAOYSA-N 0.000 claims description 8
- HFPZCAJZSCWRBC-UHFFFAOYSA-N p-cymene Chemical compound CC(C)C1=CC=C(C)C=C1 HFPZCAJZSCWRBC-UHFFFAOYSA-N 0.000 claims description 8
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 6
- DDWGAGFNZHAFFN-LWFKIUJUSA-N bicyclo[2.2.1]hepta-2,5-diene;(z)-4-hydroxypent-3-en-2-one;rhodium Chemical compound [Rh].C\C(O)=C\C(C)=O.C1=CC2C=CC1C2 DDWGAGFNZHAFFN-LWFKIUJUSA-N 0.000 claims description 5
- 229910052763 palladium Inorganic materials 0.000 claims description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 4
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 4
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 4
- 239000005977 Ethylene Substances 0.000 claims description 4
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 claims description 4
- YUWBVKYVJWNVLE-UHFFFAOYSA-N [N].[P] Chemical compound [N].[P] YUWBVKYVJWNVLE-UHFFFAOYSA-N 0.000 claims description 4
- 150000001450 anions Chemical class 0.000 claims description 4
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 4
- 229910052794 bromium Inorganic materials 0.000 claims description 4
- 229910052801 chlorine Inorganic materials 0.000 claims description 4
- 229910017052 cobalt Inorganic materials 0.000 claims description 4
- 239000010941 cobalt Substances 0.000 claims description 4
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 claims description 4
- 150000004985 diamines Chemical class 0.000 claims description 4
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 4
- 229910052741 iridium Inorganic materials 0.000 claims description 4
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 claims description 4
- 229910052742 iron Inorganic materials 0.000 claims description 4
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 4
- 229910021645 metal ion Inorganic materials 0.000 claims description 4
- HZVOZRGWRWCICA-UHFFFAOYSA-N methanediyl Chemical compound [CH2] HZVOZRGWRWCICA-UHFFFAOYSA-N 0.000 claims description 4
- 229910052759 nickel Inorganic materials 0.000 claims description 4
- 229910052762 osmium Inorganic materials 0.000 claims description 4
- SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 claims description 4
- OJMIONKXNSYLSR-UHFFFAOYSA-N phosphorous acid Chemical compound OP(O)O OJMIONKXNSYLSR-UHFFFAOYSA-N 0.000 claims description 4
- 229910052697 platinum Inorganic materials 0.000 claims description 4
- 229910052707 ruthenium Inorganic materials 0.000 claims description 4
- PNGLEYLFMHGIQO-UHFFFAOYSA-M sodium;3-(n-ethyl-3-methoxyanilino)-2-hydroxypropane-1-sulfonate;dihydrate Chemical compound O.O.[Na+].[O-]S(=O)(=O)CC(O)CN(CC)C1=CC=CC(OC)=C1 PNGLEYLFMHGIQO-UHFFFAOYSA-M 0.000 claims description 4
- ISIJQEHRDSCQIU-UHFFFAOYSA-N tert-butyl 2,7-diazaspiro[4.5]decane-7-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCCC11CNCC1 ISIJQEHRDSCQIU-UHFFFAOYSA-N 0.000 claims description 4
- ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 claims description 4
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 3
- 229910052731 fluorine Inorganic materials 0.000 claims description 3
- 239000011737 fluorine Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 2
- 230000035484 reaction time Effects 0.000 claims description 2
- YMQOSAYPQWXJSS-UHFFFAOYSA-N 3-methoxypentane-2,4-dione Chemical compound COC(C(C)=O)C(C)=O YMQOSAYPQWXJSS-UHFFFAOYSA-N 0.000 claims 2
- 230000008901 benefit Effects 0.000 abstract description 4
- 238000005984 hydrogenation reaction Methods 0.000 abstract description 3
- 229910000073 phosphorus hydride Inorganic materials 0.000 abstract description 2
- 238000000926 separation method Methods 0.000 abstract description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 54
- 229910052757 nitrogen Inorganic materials 0.000 description 32
- 238000003756 stirring Methods 0.000 description 31
- 239000000243 solution Substances 0.000 description 25
- 239000000758 substrate Substances 0.000 description 22
- 238000004817 gas chromatography Methods 0.000 description 19
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 16
- 238000001514 detection method Methods 0.000 description 15
- 238000011049 filling Methods 0.000 description 11
- 150000002431 hydrogen Chemical class 0.000 description 11
- 238000002360 preparation method Methods 0.000 description 11
- NEHNMFOYXAPHSD-SNVBAGLBSA-N (+)-Citronellal Chemical class O=CC[C@H](C)CCC=C(C)C NEHNMFOYXAPHSD-SNVBAGLBSA-N 0.000 description 10
- 239000008367 deionised water Substances 0.000 description 10
- 229910021641 deionized water Inorganic materials 0.000 description 10
- 238000004090 dissolution Methods 0.000 description 10
- 238000010813 internal standard method Methods 0.000 description 10
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 10
- 239000003921 oil Substances 0.000 description 10
- 238000005070 sampling Methods 0.000 description 10
- 230000015572 biosynthetic process Effects 0.000 description 9
- 238000003786 synthesis reaction Methods 0.000 description 9
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 8
- 229940043350 citral Drugs 0.000 description 7
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 4
- YRKCREAYFQTBPV-UHFFFAOYSA-N acetylacetone Chemical compound CC(=O)CC(C)=O YRKCREAYFQTBPV-UHFFFAOYSA-N 0.000 description 4
- VURFVHCLMJOLKN-UHFFFAOYSA-N diphosphane Chemical compound PP VURFVHCLMJOLKN-UHFFFAOYSA-N 0.000 description 4
- XIXADJRWDQXREU-UHFFFAOYSA-M lithium acetate Chemical compound [Li+].CC([O-])=O XIXADJRWDQXREU-UHFFFAOYSA-M 0.000 description 4
- MCVFFRWZNYZUIJ-UHFFFAOYSA-M lithium;trifluoromethanesulfonate Chemical compound [Li+].[O-]S(=O)(=O)C(F)(F)F MCVFFRWZNYZUIJ-UHFFFAOYSA-M 0.000 description 4
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 4
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 238000006722 reduction reaction Methods 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 2
- 150000000083 (-)-menthol derivatives Chemical class 0.000 description 2
- NEHNMFOYXAPHSD-JTQLQIEISA-N (S)-(-)-Citronellal Chemical class O=CC[C@@H](C)CCC=C(C)C NEHNMFOYXAPHSD-JTQLQIEISA-N 0.000 description 2
- 241000207199 Citrus Species 0.000 description 2
- 101100028326 Saccharomyces pastorianus OYE1 gene Proteins 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- UAHWPYUMFXYFJY-UHFFFAOYSA-N beta-myrcene Chemical compound CC(C)=CCCC(=C)C=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 2
- 235000020971 citrus fruits Nutrition 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 238000006317 isomerization reaction Methods 0.000 description 2
- NBTOZLQBSIZIKS-UHFFFAOYSA-N methoxide Chemical compound [O-]C NBTOZLQBSIZIKS-UHFFFAOYSA-N 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 238000010189 synthetic method Methods 0.000 description 2
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 1
- ZDZHCHYQNPQSGG-UHFFFAOYSA-N 1-naphthalen-1-ylnaphthalene Chemical group C1=CC=C2C(C=3C4=CC=CC=C4C=CC=3)=CC=CC2=C1 ZDZHCHYQNPQSGG-UHFFFAOYSA-N 0.000 description 1
- VYECHIIVAZFIRI-UHFFFAOYSA-N 2-aminocyclohexane-1-sulfonamide Chemical compound NC1CCCCC1S(N)(=O)=O VYECHIIVAZFIRI-UHFFFAOYSA-N 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 244000165852 Eucalyptus citriodora Species 0.000 description 1
- 235000004722 Eucalyptus citriodora Nutrition 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- HBBGRARXTFLTSG-UHFFFAOYSA-N Lithium ion Chemical compound [Li+] HBBGRARXTFLTSG-UHFFFAOYSA-N 0.000 description 1
- GLZPCOQZEFWAFX-JXMROGBWSA-N Nerol Natural products CC(C)=CCC\C(C)=C\CO GLZPCOQZEFWAFX-JXMROGBWSA-N 0.000 description 1
- GEYBMYRBIABFTA-UHFFFAOYSA-N O-methyltyrosine Chemical compound COC1=CC=C(CC(N)C(O)=O)C=C1 GEYBMYRBIABFTA-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- VYBREYKSZAROCT-UHFFFAOYSA-N alpha-myrcene Natural products CC(=C)CCCC(=C)C=C VYBREYKSZAROCT-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 238000007697 cis-trans-isomerization reaction Methods 0.000 description 1
- 239000010632 citronella oil Substances 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000002153 concerted effect Effects 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 238000006356 dehydrogenation reaction Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 150000002085 enols Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 150000007517 lewis acids Chemical class 0.000 description 1
- 229910001416 lithium ion Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 1
- 229930003658 monoterpene Natural products 0.000 description 1
- 235000002577 monoterpenes Nutrition 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229940077386 sodium benzenesulfonate Drugs 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- YPPQYORGOMWNMX-UHFFFAOYSA-L sodium phosphonate pentahydrate Chemical compound [Na+].[Na+].[O-]P([O-])=O YPPQYORGOMWNMX-UHFFFAOYSA-L 0.000 description 1
- DAUKXJQIABLQLU-MNMPKAIFSA-M sodium;4-[[(1r,2r)-2-aminocyclohexyl]sulfamoyl]benzenesulfonate Chemical compound [Na+].N[C@@H]1CCCC[C@H]1NS(=O)(=O)C1=CC=C(S([O-])(=O)=O)C=C1 DAUKXJQIABLQLU-MNMPKAIFSA-M 0.000 description 1
- MZSDGDXXBZSFTG-UHFFFAOYSA-M sodium;benzenesulfonate Chemical compound [Na+].[O-]S(=O)(=O)C1=CC=CC=C1 MZSDGDXXBZSFTG-UHFFFAOYSA-M 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- QBVXKDJEZKEASM-UHFFFAOYSA-M tetraoctylammonium bromide Chemical compound [Br-].CCCCCCCC[N+](CCCCCCCC)(CCCCCCCC)CCCCCCCC QBVXKDJEZKEASM-UHFFFAOYSA-M 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B53/00—Asymmetric syntheses
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/18—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms
- B01J31/1805—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms the ligands containing nitrogen
- B01J31/181—Cyclic ligands, including e.g. non-condensed polycyclic ligands, comprising at least one complexing nitrogen atom as ring member, e.g. pyridine
- B01J31/1815—Cyclic ligands, including e.g. non-condensed polycyclic ligands, comprising at least one complexing nitrogen atom as ring member, e.g. pyridine with more than one complexing nitrogen atom, e.g. bipyridyl, 2-aminopyridine
- B01J31/182—Cyclic ligands, including e.g. non-condensed polycyclic ligands, comprising at least one complexing nitrogen atom as ring member, e.g. pyridine with more than one complexing nitrogen atom, e.g. bipyridyl, 2-aminopyridine comprising aliphatic or saturated rings
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/24—Phosphines, i.e. phosphorus bonded to only carbon atoms, or to both carbon and hydrogen atoms, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, phosphole or anionic phospholide ligands
- B01J31/2404—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring
- B01J31/2409—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring with more than one complexing phosphine-P atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/62—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by hydrogenation of carbon-to-carbon double or triple bonds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
- B01J2231/60—Reduction reactions, e.g. hydrogenation
- B01J2231/64—Reductions in general of organic substrates, e.g. hydride reductions or hydrogenations
- B01J2231/641—Hydrogenation of organic substrates, i.e. H2 or H-transfer hydrogenations, e.g. Fischer-Tropsch processes
- B01J2231/645—Hydrogenation of organic substrates, i.e. H2 or H-transfer hydrogenations, e.g. Fischer-Tropsch processes of C=C or C-C triple bonds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/82—Metals of the platinum group
- B01J2531/822—Rhodium
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/90—Catalytic systems characterized by the solvent or solvent system used
- B01J2531/98—Phase-transfer catalysis in a mixed solvent system containing at least 2 immiscible solvents or solvent phases
- B01J2531/985—Phase-transfer catalysis in a mixed solvent system containing at least 2 immiscible solvents or solvent phases in a water / organic solvent system
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2540/00—Compositional aspects of coordination complexes or ligands in catalyst systems
- B01J2540/30—Non-coordinating groups comprising sulfur
- B01J2540/32—Sulfonic acid groups or their salts
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2540/00—Compositional aspects of coordination complexes or ligands in catalyst systems
- B01J2540/50—Non-coordinating groups comprising phosphorus
- B01J2540/52—Phosphorus acid or phosphorus acid ester groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Catalysts (AREA)
Abstract
The invention provides a method for synthesizing R-citronellal by water-oil two-phase asymmetric hydrogenation and a catalyst used in the method, and particularly relates to a method for obtaining R-citronellal by asymmetrically hydrogenating neral or geranial in a water-oil two-phase system by using hydrogen as a reducing agent and a water-soluble metal complex as a catalyst. The method has the main advantages that the water-soluble phosphine ligand is used, so that the catalyst has good water solubility, the reaction is carried out in a water-oil two-phase system, and the separation of the product R-citronellal and the catalyst can be realized by simple phase separation after the hydrogenation reaction is finished; in addition, a small amount of lithium salt is added into the reaction system, so that the enantioselectivity of the product is improved. Finally, the catalyst dissolved in water can be recycled for many times, so that the catalyst cost is greatly reduced.
Description
Technical Field
The invention belongs to the field of fine chemical industry and flavors and fragrances, and particularly relates to a method for synthesizing R-citronellal by asymmetrically hydrogenating citral in a water-oil two-phase system and a catalyst used in the method.
Background
Citronellal is a chain-shaped monoterpene aldehyde, naturally exists in citronella oil and eucalyptus citriodora oil, has strong and fresh citrus breath, can be used for preparing citrus and cherry essence and can also be used for preparing soap essence, the consumption of citronellal in the two aspects is small, and more citronellal is used for synthesizing cooling agents such as menthol, mentha-carboxamide and the like. Due to the fact that the molecular structure of the L-menthol derivative has a chiral center, citronellal has two optical isomers of (R) -citronellal and (S) -citronellal, wherein the (R) -citronellal can be used for synthesizing natural L-menthol, and therefore the L-menthol derivative has higher economic value. Chiral synthesis of (R) -citronellal has attracted attention since a long time, and over the course of many years of effort, chemists have developed various chiral synthesis methods for (R) -citronellal, including asymmetric hydrogenation of neral or geranial, myrcene, dehydrogenation of chiral citronellol, isomerization of nerol or geraniol, and the like. Among the synthetic methods of citronellal, the neral or geranial asymmetric hydrogenation method has the advantages of easily available raw materials, simple reaction and good chiral control, and is the most studied synthetic method of chiral citronellal by people at present.
As early as 1982, Varagnat et al achieved asymmetric hydrogenation of neral and geranial using rhodium carbonyl and chiral bisphosphine ligands, yielding chiral citronellal products in good yields up to 71% ee value (J.mol.Cat.1982,16, 51). In patent CN101932543, neral and geranial are separated by distillation, and then neral or geranial is reduced by rhodium and chiral diphosphine ligand in hydrogen atmosphere containing part of carbon monoxide to obtain chiral citronellal product, ee value can reach 90% at most, in an example reported in which a continuous hydrogenation reaction is performed, S/C reaches 10941 at most.
Patents CN102458659 and CN103249484 adopt metal powders or supported metal catalysts of groups 8 to 10, such as palladium carbon, palladium alumina, etc., under the concerted catalysis of chiral cyclic amine and acid, the asymmetric hydrogenation of citral is realized, chiral citronellal is obtained, and ee is up to 91%.
Patent CN101932543 utilizes chiral rhodium catalyst, under the action of additives such as sodium iodide, tetra-n-octylammonium bromide, phenyltriethylammonium chloride, etc., to implement asymmetric hydrogenation of neral or geranial, the optical purity of the obtained citronellal is 72-98%, and the yield can reach 71-99%. The patent CN106086089A utilizes an enzyme method to asymmetrically reduce citral, combines amino acid catalyzed citral cis-trans isomerization with saccharomyces cerevisiae enol reductase OYE1 catalyzed citral asymmetric reduction reaction, and obtains a chiral citronellal product. When the reductase OYE1 is reduced, neral reacts to obtain (S) -citronellal, geranial reacts to obtain (R) -citronellal, the reduction speed of the geranial is higher than that of the neral, and the ee value of the citronellal can reach 65.4 percent at most.
In summary, although there are many reports on chiral citronellal obtained by asymmetric reduction of citral at present, these reports basically adopt expensive metal rhodium catalyst and chiral diphosphine ligand, the catalyst not only has large dosage, but also after the reaction is finished, the catalyst can not be recovered, or the recovery and reuse conditions are harsh, the flow is complex, so the economic cost is high, and the benefit is poor. In order to reduce the cost of R-citronellal, a high-efficiency citral asymmetric hydrogenation system needs to be developed, so that the cost of the catalyst is reduced, and better economic benefit is brought.
Disclosure of Invention
The invention aims to provide a catalyst and a method for synthesizing R-citronellal by asymmetric hydrogenation in water and oil phases.
According to a first aspect of the present invention, there is provided a process for the asymmetric hydrogenation of R-citronellal in a two-phase water-oil phase, which comprises: hydrogen is used as a reducing agent, a water-soluble metal complex is used as a catalyst, and neral or geranial is asymmetrically hydrogenated in a water-oil two-phase system to obtain R-citronellal; after the reaction is finished, separating citronellal and the catalyst by oil-water split-phase separation;
the water-soluble metal complex comprises a metal precursor and a water-soluble ligand,
wherein the metal precursor has the formula [ M (X) Y]Wherein M represents a metal ion including, but not limited to, ruthenium, rhodium, iridium, nickel, palladium, platinum, osmium, manganese, cobalt, iron, and the like, preferably rhodium metal; x represents a coordinating group including, but not limited to, ethylene, 1, 4-cyclooctadiene, norbornadiene, p-cymene, carbon monoxide, and the like, preferably carbon monoxide, 1, 4-cyclooctadiene, and norbornadiene; y represents an anion including, but not limited to, fluorine, chlorine, bromine, iodine, trifluoromethanesulfonic acid, tetrafluoroboric acid, hexafluorophosphoric acid, methoxide, acetylacetone, acetate, and the like. Examples of such metal precursors are, for example, Rh (CO)2(acac),[Rh(COD)2(OTf)],[Rh(COD)Cl]2,[Rh(NBD)(acac)]Purchased from Sigma-Aldrich.
Further, the water-soluble ligand includes, but is not limited to, water-soluble bisphosphine ligand, monophosphine ligand, phosphorous acid ligand, phosphite ligand, nitrogen phosphorus ligand, diamine ligand, carbene ligand, and the like, preferably 5,5 '-phospho-R-BINAP, 5' -sodium sulfonate-R-BINAP, sulfonate-R, R-chiralphos, sulfonate-R, R-DPCP, sodium 4- ((2-amino-1, 2-diphenylethyl) sulfamoyl) benzenesulfonate, sodium 4- ((2-aminocyclohexyl) sulfamoyl) benzenesulfonate, sodium 4- ((2-amino-2-phenylethyl) sulfamoyl) benzenesulfonate.
The catalyst of the invention can be recycled for many times.
Further, the water-oil two-phase system (isomerization reaction system) is composed of water and oil phases, wherein the oil phase is a raw material phase or a product phase, the water phase is a catalyst phase, and the amount of water is 0.3-3.0 times, preferably 0.5-1.0 times of the mass of the raw material.
Further, the water-soluble metal complex is prepared in situ in the reactor from a metal precursor and a water-soluble ligand.
Further, the ratio of the metal precursor to the ligand is 1.0:0.5 to 10.0, preferably 1.0:1.01 to 5.0, more preferably about 1.0:1.1 to 2.0, and the preparation method is as follows: mixing the metal precursor, the water-soluble ligand and the solvent and optional lithium salt, for example, stirring and coordinating at room temperature for more than 10 minutes, and obtaining a complex solution after the metal precursor and the ligand are completely dissolved; wherein the solvent is preferably selected from tetrahydrofuran, methanol, ethanol, isopropanol, N-dimethylformamide and other organic solvents with good water solubility.
Further, the amount of the metal catalyst is 0.005-1 mol%, preferably 0.01-0.5 mol%, and more preferably 0.06-0.42 mol% of the molar amount of neral or geranial.
In a preferred embodiment, the catalyst further comprises a lithium salt, and the amount of the lithium salt is 1.0 to 4.0 times, preferably 2.0 to 3.0 times, the molar amount of the metal precursor. The metal is preferably rhodium metal. The lithium ion has stronger Lewis acid acidity, can coordinate with carbonyl, and improves the hydrogenation reaction selectivity. The lithium salt is selected from one or more of lithium chloride, lithium bromide, lithium acetate, lithium trifluoromethanesulfonate, etc.
In the invention, the pressure of the hydrogen is 1.0-10.0 MPa, preferably 6.0-8.0 MPa, and/or the reaction temperature is 40-120 ℃, preferably 70-80 ℃, and the reaction time is 6-12 hours, preferably 6-8 hours.
In the invention, after the reaction is finished, the reaction solution is cooled to room temperature, then the reaction solution is kept stand for phase separation, so that the separation of a product and a water phase can be realized, and the water phase containing the catalyst can be reused for more than 5 times.
According to a second aspect of the present invention there is provided a catalyst comprising a metal precursor and a water-soluble ligand,
wherein the metal precursor has the formula [ M (X) Y]Wherein M represents a metal ion including, but not limited to, ruthenium, rhodium, iridium, nickel, palladium, platinum, osmium, manganese, cobalt, iron, and the like, preferably rhodium metal; x represents a coordinating group including, but not limited to, ethylene, 1, 4-cyclooctadiene, norbornadiene, p-cymene, carbon monoxide, and the like, preferably carbon monoxide, 1, 4-cyclooctadiene, and norbornadiene; y represents an anion, including but not limited toFluorine, chlorine, bromine, iodine, trifluoromethanesulfonic acid, tetrafluoroboric acid, hexafluorophosphoric acid, methoxide, acetylacetone, acetate, and the like. Examples of such metal precursors are, for example, Rh (CO)2(acac),[Rh(COD)2(OTf)],[Rh(COD)Cl]2,[Rh(NBD)(acac)]Purchased from Sigma-Aldrich.
Further, the water-soluble ligand includes, but is not limited to, water-soluble bisphosphine ligand, monophosphine ligand, phosphorous acid ligand, phosphite ligand, nitrogen phosphorus ligand, diamine ligand, carbene ligand, and the like, preferably 5,5 '-phospho-R-BINAP, 5' -sodium sulfonate-R-BINAP, sulfonate-R, R-chiralphos, sulfonate-R, R-DPCP, sodium 4- ((2-amino-1, 2-diphenylethyl) sulfamoyl) benzenesulfonate, sodium 4- ((2-aminocyclohexyl) sulfamoyl) benzenesulfonate, sodium 4- ((2-amino-2-phenylethyl) sulfamoyl) benzenesulfonate.
Further, the catalyst also comprises a lithium salt, and the dosage of the lithium salt is 2.0 to 4.0 times of the molar quantity of the metal precursor, and preferably 2.0 to 3.0 times. The metal is preferably rhodium metal. The lithium salt is selected from one or more of lithium chloride, lithium bromide, lithium acetate, lithium trifluoromethanesulfonate, etc.
According to a third aspect of the present invention, there is provided a method for producing the above catalyst, comprising: the metal precursor, the water-soluble ligand and the solvent are mixed, and the molar ratio of the metal precursor to the water-soluble ligand is 1.0:0.5 to 10.0, preferably 1.0:1.01 to 5.0, and more preferably about 1.0:1.1 to 2.0. Wherein the solvent is preferably selected from tetrahydrofuran, methanol, ethanol, isopropanol, N-dimethylformamide and other organic solvents with good water solubility. The amount of the solvent used is, for example, 2 to 50 times, preferably 5 to 20 times the total mass of the metal precursor and the water-soluble ligand.
Further, the method further comprises adding a lithium salt, wherein the amount of the lithium salt is 1.0-4.0 times, preferably 2.0-3.0 times of the molar amount of the metal precursor. The metal is preferably rhodium metal.
By adopting the technical scheme, the invention has the following positive effects:
1. the water-soluble ligand is used, so that the catalyst is low in consumption and can be recycled, and the catalyst cost is greatly reduced;
2. the catalyst is prepared by rhodium metal precursor and water-soluble phosphine ligand in situ, the process is simple, the operation is convenient, and the method is suitable for large-scale production;
3. the addition of lithium salt in the reaction system can accelerate the reaction and improve the stereoselectivity. The obtained chiral citronellal product has high yield and good stereoselectivity.
Detailed Description
The present invention will be described in more detail by way of examples, but the present invention is not limited to the following examples.
The main raw material information is as follows:
neral and geranial, 99.5% (GC), self-made;
tetrahydrofuran, Chinese medicine reagent and chromatographic purity;
Rh(CO)2(acac),[Rh(COD)2(OTf)],[Rh(COD)Cl]2,[Rh(NBD)(acac)]Sigma-Aldrich, 99%; sulfonated-R, R-chiralphos, 4,4 '-sodium phosphate-BINAP, 5,5' -sodium sulfonate-BINAP, (1R,2R) -4- ((2-aminocyclohexyl) sulfonamide) sodium benzenesulfonate, sulfonated-R, R-DPCP, synnaonoceae, 98%;
lithium chloride, lithium bromide, lithium acetate, lithium trifluoromethanesulfonate and an avadin reagent, wherein the percentage of the total weight of the solution is 99%.
The gas chromatography test conditions of the present invention are as follows:
the instrument model is Agilent GC, the chromatographic column is Agilent Supelco β -DEX 225(30m is multiplied by 0.25mm is multiplied by 0.25 mu m), the column temperature is 60 ℃, the temperature is increased to 80 ℃ at 5 ℃/min, then the temperature is increased to 150 ℃ at 10 ℃/min, finally the temperature is increased to 210 ℃ at 15 ℃/min, the temperature is kept for 5min, the injection port temperature is 280 ℃, the FID detector temperature is 300 ℃, the split injection is carried out, the split ratio is 60:1, the injection amount is 2.0 mu L, H2Flow rate: 40 mL/min; air flow rate: 400 mL/min.
Example 1
Catalyst preparation in a glove box, a metal precursor [ Rh (CO) ] was added sequentially to a single-neck flask equipped with a magnetic stirrer2(acac)](26.1mg,0.10mmol), sulfonated-R, R-DPCP (3,3' - (((1R,2R) -cyclobutane-1, 2-diylbis (methylene)) bis (phosphinotriyl)) sodium tetraphenylsulfonate) (91.9mg,0.11mmol) Starting stirring, promoting the dissolution of a metal precursor and a ligand, stirring and coordinating for 20 minutes to obtain a catalyst solution, sealing a single-mouth bottle by using a rubber plug, taking out of a glove box, and protecting by using a nitrogen balloon for later use.
Synthesis of R-citronellal by asymmetric hydrogenation of neral
The 250mL autoclave was sealed, pressure maintained, and after no problem was detected by leak detection, the autoclave was replaced with nitrogen 3 times. Addition was made by first feeding deoxygenated deionized water (10.0g,10.0mL) into the reactor using an advection pump, followed by the previously prepared catalyst solution, starting the autoclave with stirring, and finally adding the substrate neral (30.754g,0.2 mol). After the substrate is added, replacing nitrogen by hydrogen for three times, wherein each time is 2.0MPa, finally filling 6.0MPa hydrogen, starting the autoclave for heat tracing, starting timing when the temperature in the autoclave reaches 80 ℃, keeping the temperature for reaction for 6 hours, sampling and analyzing at regular time, detecting by GC, and determining the yield by an internal standard method, wherein the result shows that the yield of citronellal is 99.6 percent, and the ee value is 94.2 percent (R isomer is main).
Example 2
Preparation of the catalyst
In a glove box, a metal precursor [ Rh (CO) ] was added to a single-neck flask equipped with a magnetic stirrer in sequence2(acac)](140.3mg,0.40mmol), sulfonated-R, R-DPCP (3,3' - (((1R,2R) -cyclobutane-1, 2-diylbis (methylene)) bis (phosphinotriyl)) sodium tetraphenylsulfonate) (382.5mg,0.44mmol), lithium chloride (42.8mg,1.0mmol) and tetrahydrofuran (8.0mL), stirring was started to promote dissolution of the metal precursor and ligand, and after 20 minutes of coordination by stirring, a catalyst solution was obtained, a single-neck flask was sealed with a rubber stopper, taken out of a glove box and protected with a nitrogen balloon for use.
Synthesis of R-citronellal by asymmetric hydrogenation of neral
The 250mL autoclave was sealed, pressure maintained, and after no problem was detected by leak detection, the autoclave was replaced with nitrogen 3 times. Addition was made by first feeding deoxygenated deionized water (20.0g,20.0mL) into the reactor using an advection pump, followed by the previously prepared catalyst solution, starting the autoclave with stirring, and finally adding the substrate neral (30.754g,0.2 mol). After the substrate is added, replacing nitrogen by hydrogen for three times, wherein each time is 2.0MPa, finally filling 10.0MPa hydrogen, starting the autoclave for heat tracing, starting timing when the temperature in the autoclave reaches 40 ℃, keeping the temperature for reaction for 12 hours, sampling and analyzing at regular time, detecting by GC, and determining the yield by an internal standard method, wherein the result shows that the yield of citronellal is 99.8 percent, and the ee value is 94.3 percent (R isomer is main).
Example 3
Preparation of the catalyst
In a glove box, a metal precursor [ Rh (CO) ] was added to a single-neck flask equipped with a magnetic stirrer in sequence2(acac)](52.1mg,0.20mmol), sulfonated-R, R-DPCP (3,3' - (((1R,2R) -cyclobutane-1, 2-diylbis (methylene)) bis (phosphinotriyl)) sodium tetraphenylsulfonate) (191.3mg,0.22mmol), lithium chloride (25.7mg,0.60mmol) and tetrahydrofuran (4.0mL), stirring was turned on to promote dissolution of the metal precursor and ligand, and after 20 minutes of coordination by stirring, a catalyst solution was obtained, a single vial was sealed with a rubber stopper, taken out of a glove box and protected with a nitrogen balloon for use.
Synthesis of R-citronellal by asymmetric hydrogenation of neral
The 250mL autoclave was sealed, pressure maintained, and after no problem was detected by leak detection, the autoclave was replaced with nitrogen 3 times. Addition was made by first feeding deoxygenated deionized water (20.0g,20.0mL) into the reactor using an advection pump, followed by the previously prepared catalyst solution, starting the autoclave with stirring, and finally adding the substrate neral (30.754g,0.2 mol). After the substrate is added, replacing nitrogen by hydrogen for three times, each time is 2.0MPa, finally filling 3.0MPa hydrogen, starting the autoclave for heat tracing, starting timing when the temperature in the autoclave reaches 100 ℃, keeping the temperature for reaction for 6 hours, sampling and analyzing at regular time, carrying out GC (gas chromatography) detection, and determining the yield by an internal standard method, wherein the result shows that the yield of the citronellal is 99.1 percent, and the ee value is 92.4 percent (the R isomer is main).
Example 4
Preparation of the catalyst
In a glove box, a metal precursor [ Rh (CO) ] was added to a single-neck flask equipped with a magnetic stirrer in sequence2(acac)](5.2mg,0.02mmol), sulfonated-R, R-DPCP (3,3' - (((1R,2R) -cyclobutane-1, 2-diylbis (methylene)) bis (phosphinotriyl)) sodium tetraphenylsulfonate) (19.1mg,0.022mmol) and tetrahydrofuran (1.0mL), stirring was turned on,promoting the dissolution of the metal precursor and the ligand, stirring and coordinating for 20 minutes to obtain a catalyst solution, sealing the single-mouth bottle by using a rubber plug, discharging from a glove box, and protecting by using a nitrogen balloon for later use.
Asymmetrically hydrogenating neral to synthesize R-citronellal without adding lithium salt
The 250mL autoclave was sealed, pressure maintained, and after no problem was detected by leak detection, the autoclave was replaced with nitrogen 3 times. Addition was made by first feeding deoxygenated deionized water (30.7g,30.7mL) into the reactor using an advection pump, followed by the previously prepared catalyst solution, starting the autoclave with stirring, and finally adding the substrate neral (30.754g,0.2 mol). After the substrate is added, replacing nitrogen by hydrogen for three times, wherein each time is 2.0MPa, finally filling 3.0MPa hydrogen, starting the autoclave for heat tracing, starting timing when the temperature in the autoclave reaches 100 ℃, keeping the temperature for 10 hours, sampling and analyzing at regular time, carrying out GC (gas chromatography) detection, and determining the yield by an internal standard method, wherein the result shows that the yield of the citronellal is 80.2 percent, and the ee value is 88.5 percent (the R isomer is main).
Example 5
Preparation of the catalyst
In a glove box, a metal precursor [ Rh (CO) ] was added to a single-neck flask equipped with a magnetic stirrer in sequence2(acac)](26.1mg,0.10mmol), sulfonated-R, R-chiralPhos (3,3' - ((2R,3R) -2, 3-dimethylbutane-1, 4-diyl) bis (phosphinotriyl)) sodium tetraphenylsulfonate) (113.3mg,0.13mmol), lithium chloride (12.8mg,0.30mmol) and tetrahydrofuran (4.0mL) were started to stir, to promote dissolution of the metal precursor and ligand, to obtain a catalyst solution after 20 minutes of coordination by stirring, and a single vial was sealed with a rubber stopper, taken out of the glove box and protected with a nitrogen balloon for future use.
Synthesis of R-citronellal by asymmetric hydrogenation of neral
The 250mL autoclave was sealed, pressure maintained, and after no problem was detected by leak detection, the autoclave was replaced with nitrogen 3 times. Addition was made by first feeding deoxygenated deionized water (10.0g,10.0mL) into the reactor using an advection pump, followed by the previously prepared catalyst solution, starting the autoclave with stirring, and finally adding the substrate neral (30.754g,0.2 mol). After the substrate is added, replacing nitrogen by hydrogen for three times, each time is 2.0MPa, finally filling 6.0MPa hydrogen, starting the autoclave for heat tracing, starting timing when the temperature in the autoclave reaches 70 ℃, keeping the temperature for reaction for 6 hours, sampling and analyzing at regular time, carrying out GC (gas chromatography) detection, and determining the yield by an internal standard method, wherein the result shows that the yield of the citronellal is 99.6 percent, and the ee value is 96.1 percent (the R isomer is main).
Example 6
Preparation of the catalyst
In the glove box, a metal precursor [ rh (nbd) (acac)) (29.7mg,0.10mmol), 4 '-sodium phosphate-BINAP ((2,2' -bis (diphenylphosphino) - [1,1 '-binaphthyl ] -4,4' -diyl) bis (sodium phosphonate)) (131.9mg,0.15mmol), lithium bromide (26.3mg,0.30mmol) and ethanol (6.0mL) were added in this order to a single-neck flask equipped with a magnetic stirrer, stirring was started to promote dissolution of the metal precursor and the ligand, and after 20 minutes of coordination by stirring, a catalyst solution was obtained, the single-neck flask was sealed with a rubber stopper, taken out of the glove box, and protected with a nitrogen balloon for future use.
Synthesis of R-citronellal by asymmetric hydrogenation of neral
The 250mL autoclave was sealed, pressure maintained, and after no problem was detected by leak detection, the autoclave was replaced with nitrogen 3 times. Addition was made by first feeding deoxygenated deionized water (10.0g,10.0mL) into the reactor using an advection pump, followed by the previously prepared catalyst solution, starting the autoclave with stirring, and finally adding the substrate neral (30.754g,0.2 mol). After the substrate is added, replacing nitrogen by hydrogen for three times, each time is 2.0MPa, finally filling 6.0MPa hydrogen, starting the autoclave for heat tracing, starting timing when the temperature in the autoclave reaches 80 ℃, keeping the temperature for reaction for 6 hours, sampling and analyzing at regular time, detecting by GC, determining the yield by an internal standard method, and the result shows that the yield of citronellal is 95.5 percent and the ee value is 90.5 percent (R isomer is main).
Example 7
Preparation of the catalyst
In a glove box, a metal precursor [ Rh (COD) Cl ] was added to a single-neck flask equipped with a magnetic stirrer in sequence]2(49.8mg,0.10mmol), 5' -sodium sulfonate-BINAP ((2,2' -bis (diphenylphosphino) - [1,1' -binaphthyl) -)]-5,5' -diyl) sodium sulfonate) (167.0mg,0.20mmol), lithium acetate (20.0mg,0.30mmol) and N, N-dimethylformamide (4.0mL), stirring was turned on to promote dissolution of the metal precursor and ligand, and after stirring for 20 minutes of coordination, catalysis was obtainedSealing the single-mouth bottle with a rubber plug, discharging the solution out of the glove box, and protecting the solution with a nitrogen balloon for later use.
Synthesis of R-citronellal by asymmetric hydrogenation of neral
The 250mL autoclave was sealed, pressure maintained, and after no problem was detected by leak detection, the autoclave was replaced with nitrogen 3 times. Addition was made by first feeding deoxygenated deionized water (10.0g,10.0mL) into the reactor using an advection pump, followed by the previously prepared catalyst solution, starting the autoclave with stirring, and finally adding the substrate neral (30.754g,0.2 mol). After the substrate is added, replacing nitrogen by hydrogen for three times, wherein each time is 2.0MPa, finally filling 6.0MPa hydrogen, starting the autoclave for heat tracing, starting timing when the temperature in the autoclave reaches 80 ℃, keeping the temperature for reaction for 8 hours, sampling and analyzing at regular time, detecting by GC, determining the yield by an internal standard method, and the result shows that the yield of the citronellal is 96.5 percent and the ee value is 91.2 percent (the R isomer is main).
Example 8
Preparation of the catalyst
In a glove box, a metal precursor [ Rh (COD) ] was added to a single-neck flask equipped with a magnetic stirrer in sequence2OTf](9.5mg,0.10mmol), (1R,2R) -4- ((2-aminocyclohexyl) sulfamoyl) benzenesulfonic acid sodium salt 4- (N- ((1R,2R) -2-aminocyclohexyl) sulfamoyl) benzanesulfonic acid) (40.36mg,0.12mmol), lithium trifluoromethanesulfonate (31.67mg,0.2mmol) and tetrahydrofuran (1.0mL), stirring was started to promote dissolution of the metal precursor and the ligand, and after stirring and coordination for 20 minutes, a catalyst solution was obtained, and a single vial was sealed with a rubber stopper, taken out of a glove box and protected with a nitrogen balloon for use.
Synthesis of R-citronellal by asymmetric hydrogenation of neral
The 250mL autoclave was sealed, pressure maintained, and after no problem was detected by leak detection, the autoclave was replaced with nitrogen 3 times. Addition was made by first feeding deoxygenated deionized water (10.0g,10.0mL) into the reactor using an advection pump, followed by the previously prepared catalyst solution, starting the autoclave with stirring, and finally adding the substrate neral (30.754g,0.2 mol). After the substrate is added, replacing nitrogen by hydrogen for three times, each time is 2.0MPa, finally filling 6.0MPa hydrogen, starting the autoclave for heat tracing, starting timing when the temperature in the autoclave reaches 80 ℃, keeping the temperature for reaction for 8 hours, sampling and analyzing at regular time, detecting by GC, determining the yield by an internal standard method, and the result shows that the yield of the citronellal is 99.1 percent and the ee value is 95.1 percent (the R isomer is main).
Example 9
Preparation of the catalyst
In a glove box, a metal precursor [ Rh (CO) ] was added to a single-neck flask equipped with a magnetic stirrer in sequence2(acac)](26.1mg,0.10mmol), sulfonated-S, S-chiralPhos (3,3' - ((2S,3S) -2, 3-dimethylbutane-1, 4-diyl) bis (phosphinotriyl)) sodium tetraphenylsulfonate) (113.3mg,0.13mmol), lithium chloride (12.8mg,0.30mmol) and tetrahydrofuran (3.0mL), stirring was started to promote dissolution of the metal precursor and ligand, and after 20 minutes of coordination by stirring, a catalyst solution was obtained, a single vial was sealed with a rubber stopper, taken out of the glove box and protected with a nitrogen balloon for future use.
Synthesis of R-citronellal by asymmetric hydrogenation of geranial
The 250mL autoclave was sealed, pressure maintained, and after no problem was detected by leak detection, the autoclave was replaced with nitrogen 3 times. Addition was made by first feeding deoxygenated deionized water (10.0g,10.0mL) into the reactor using an advection pump, followed by the previously prepared catalyst solution, starting the autoclave with stirring, and finally adding the substrate neral (30.754g,0.2 mol). After the substrate is added, replacing nitrogen by hydrogen for three times, each time is 2.0MPa, finally filling 7.0MPa hydrogen, starting the autoclave for heat tracing, starting timing when the temperature in the autoclave reaches 80 ℃, keeping the temperature for reaction for 8 hours, sampling and analyzing at regular time, carrying out GC (gas chromatography) detection, and determining the yield by an internal standard method, wherein the result shows that the yield of the citronellal is 99.8 percent, and the ee value is 96.7 percent (the R isomer is main).
Comparative example 1
Asymmetric hydrogenation of cis-citral in the presence of carbon monoxide (patent CN101932543)
Under a protective gas atmosphere, 17.9mg of Rh (CO)2acac and 38.5mg of (R, R) -chiralphos were dissolved in 20g of toluene and transferred to a 100ml autoclave which had been flushed 3 times beforehand with a mixture of carbon monoxide and hydrogen (1:1, vol/vol). The mixture is mixed in 1:1CO/H2The mixture was stirred at 60 ℃ for 3 hours under 8 bar and then cooled to room temperature. Then 15 bar H by means of a pressure lock2Injecting 10.94g of orange flowerAldehyde (neral/geranial double bond isomer ratio 99.1: 0.9; substrate/catalyst ratio 1000). The reaction pressure was adjusted to 80 bar by injecting hydrogen. To reduce the CO partial pressure, the pressure was reduced 3 times and after a further 3 hours again to 8 bar, and then brought back to 80 bar by injecting hydrogen. After 18 hours, the conversion was 99.9% and the yield of D-citronellal was 99.8%, as determined by gas chromatography, with an optical purity of 90% ee.
Examples 10 to 14
Preparation of the catalyst
In a glove box, a metal precursor [ Rh (CO) ] was added to a single-neck flask equipped with a magnetic stirrer in sequence2(acac)](10.4mg,0.04mmol), sulfonated-R, R-chiralPhos (3,3' - ((2R,3R) -2, 3-dimethylbutane-1, 4-diyl) bis (phosphinotriyl)) sodium tetraphenylsulfonate) (69.7mg,0.08mmol), lithium chloride (5.1mg,0.12mmol) and tetrahydrofuran (2.0mL) were started to stir, to promote dissolution of the metal precursor and ligand, to obtain a catalyst solution after 20 minutes of coordination by stirring, and a single-neck flask was sealed with a rubber stopper, taken out of a glove box, and protected with a nitrogen balloon for future use.
Experiment for synthesizing R-citronellal by asymmetrically hydrogenating neral and mechanically applying catalyst
The 250mL autoclave was sealed, pressure maintained, and after no problem was detected by leak detection, the autoclave was replaced with nitrogen 3 times. Addition was made by first feeding deoxygenated deionized water (10.0g,10.0mL) into the reactor using an advection pump, followed by the previously prepared catalyst solution, starting the autoclave with stirring, and finally adding the substrate neral (30.754g,0.2 mol). And (3) after adding the substrate, replacing nitrogen by hydrogen for three times with 2.0MPa each time, finally filling 8.0MPa hydrogen, starting the autoclave for heat tracing, starting timing when the temperature in the autoclave reaches 80 ℃, carrying out heat preservation reaction for 6-10 hours, sampling and analyzing at regular time, carrying out GC detection, and determining the yield by an internal standard method.
Releasing high-pressure hydrogen in the reaction kettle, replacing the nitrogen for 3 times, keeping the micro-positive pressure in the kettle, pressing the oil phase out of the reaction kettle carefully through a bottom inserting pipe, remaining the water phase in the kettle, and detecting the yield and the ee value of the citronellal by GC. And (2) adding a substrate neral (30.754g,0.2mol) into the autoclave again, replacing nitrogen with hydrogen for three times, wherein each time is 2.0MPa, finally filling 8.0MPa of hydrogen, starting heating, raising the internal temperature of the reaction kettle to 80 ℃, keeping the temperature constant, and repeating the operation after keeping the temperature for 6-10 hours. The catalyst in the water phase can be recycled for more than 5 times, and the specific reaction results are shown in the following table.
Examples 10 to 14 reaction results
Claims (10)
1. A process for the asymmetric hydrogenation of R-citronellal in a two-phase water-oil phase, comprising: hydrogen is used as a reducing agent, a water-soluble metal complex is used as a catalyst, and neral or geranial is asymmetrically hydrogenated in a water-oil two-phase system to obtain R-citronellal; after the reaction is finished, separating citronellal and the catalyst by oil-water split-phase separation;
the water-soluble metal complex comprises a metal precursor and a water-soluble ligand,
wherein the metal precursor has the formula [ M (X) Y ], wherein M represents a metal ion, preferably selected from ruthenium, rhodium, iridium, nickel, palladium, platinum, osmium, manganese, cobalt, iron, more preferably rhodium metal;
x represents a coordinating group, preferably selected from ethylene, 1, 4-cyclooctadiene, norbornadiene, p-cymene, carbon monoxide, preferably carbon monoxide, 1, 4-cyclooctadiene and norbornadiene;
y represents an anion, preferably selected from fluorine, chlorine, bromine, iodine, trifluoromethanesulfonic acid, tetrafluoroboric acid, hexafluorophosphoric acid, methoxy, acetylacetone, acetate.
2. The method of claim 1, wherein the metal precursor is selected from Rh (CO)2(acac),[Rh(COD)2(OTf)],[Rh(COD)Cl]2,[Rh(NBD)(acac)](ii) a And/or
The water-soluble ligand is selected from the group consisting of water-soluble bisphosphine ligands, monophosphine ligands, phosphorous acid ligands, phosphite ligands, nitrogen phosphorus ligands, diamine ligands, carbene ligands, preferably 5,5 '-phospho-R-BINAP, 5' -sodium sulfonate-R-BINAP, sulfonate-R, R-ChiraPhos, sulfonate-R, R-DPCP, sodium 4- ((2-amino-1, 2-diphenylethyl) sulfamoyl) benzenesulfonate, sodium 4- ((2-aminocyclohexyl) sulfamoyl) benzenesulfonate, sodium 4- ((2-amino-2-phenylethyl) sulfamoyl) benzenesulfonate.
3. The method according to claim 1 or 2, wherein the water-oil two-phase system consists of water-oil two phases, wherein the oil phase is a raw material phase or a product phase, the water phase is a catalyst phase, and the amount of water is 0.3-3.0 times, preferably 0.5-1.0 times of the mass of the raw material.
4. A process according to any one of claims 1 to 3, wherein the molar ratio of metal precursor to ligand is from 1.0:0.5 to 10.0, preferably from 1.0:1.01 to 5.0, more preferably from about 1.0:1.1 to 2.0.
5. The method according to any one of claims 1 to 4, wherein the metal complex catalyst is used in an amount of 0.01 to 0.5 mol%, preferably 0.06 to 0.42 mol%, based on the molar amount of neral or geranial.
6. The process according to any one of claims 1 to 5, wherein the catalyst further comprises a lithium salt in an amount of 1.0 to 4.0 times, preferably 2.0 to 3.0 times, the molar amount of the metal precursor.
7. The process according to any one of claims 1 to 6, wherein the pressure of the hydrogen is 1.0 to 10.0MPa, preferably 6.0 to 8.0MPa, and/or the reaction temperature is 40 to 120 ℃, preferably 70 to 80 ℃, and the reaction time is 6 to 12 hours, preferably 6 to 8 hours.
8. A catalyst comprising a metal precursor and a water-soluble ligand,
wherein the metal precursor has the formula [ M (X) Y ], wherein M represents a metal ion, preferably selected from ruthenium, rhodium, iridium, nickel, palladium, platinum, osmium, manganese, cobalt, iron, more preferably rhodium metal;
x represents a coordinating group, preferably selected from ethylene, 1, 4-cyclooctadiene, norbornadiene, p-cymene, carbon monoxide, more preferably carbon monoxide, 1, 4-cyclooctadiene or norbornadiene;
y represents an anion, preferably selected from fluorine, chlorine, bromine, iodine, trifluoromethanesulfonic acid, tetrafluoroboric acid, hexafluorophosphoric acid, methoxy, acetylacetone, acetate;
preferably, the water-soluble ligand is selected from the group consisting of water-soluble bisphosphine ligands, monophosphine ligands, phosphorous acid ligands, phosphite ligands, nitrogen phosphorus ligands, diamine ligands, carbene ligands, more preferably from the group consisting of 5,5 '-phospho-R-BINAP, 5' -sodium sulfonate-R-BINAP, sulfonate-R, R-chiralphos, sulfonate-R, R-DPCP, sodium 4- ((2-amino-1, 2-diphenylethyl) sulfamoyl) benzenesulfonate, sodium 4- ((2-aminocyclohexyl) sulfamoyl) benzenesulfonate, sodium 4- ((2-amino-2-phenylethyl) sulfamoyl) benzenesulfonate.
9. The catalyst according to claim 8, wherein the catalyst further comprises a lithium salt in an amount of 1.0 to 4.0 times, preferably 2.0 to 3.0 times, the molar amount of the metal precursor.
10. A method of preparing a catalyst according to claim 8 or 9, the method comprising: mixing a metal precursor, a water-soluble ligand and a solvent, wherein the molar ratio of the metal precursor to the water-soluble ligand is 1.0: 0.5-10.0, preferably 1.0:1.01-5.0, and more preferably about 1.0: 1.1-2.0;
preferably, the solvent used is selected from tetrahydrofuran, methanol, ethanol, isopropanol, N-dimethylformamide; and/or
The amount of the solvent to be used is, for example, 2 to 50 times, preferably 5 to 20 times, the total mass of the metal precursor and the water-soluble ligand; and/or
The method further comprises adding a lithium salt, wherein the amount of the lithium salt is 1.0-4.0 times, preferably 2.0-3.0 times of the molar amount of the metal precursor.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911237004.0A CN110963902B (en) | 2019-12-05 | 2019-12-05 | Method for synthesizing R-citronellal by water-oil two-phase asymmetric hydrogenation and catalyst used in method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911237004.0A CN110963902B (en) | 2019-12-05 | 2019-12-05 | Method for synthesizing R-citronellal by water-oil two-phase asymmetric hydrogenation and catalyst used in method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110963902A true CN110963902A (en) | 2020-04-07 |
CN110963902B CN110963902B (en) | 2023-01-13 |
Family
ID=70033016
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911237004.0A Active CN110963902B (en) | 2019-12-05 | 2019-12-05 | Method for synthesizing R-citronellal by water-oil two-phase asymmetric hydrogenation and catalyst used in method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110963902B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111718250A (en) * | 2020-06-28 | 2020-09-29 | 万华化学集团股份有限公司 | Method for preparing R-citronellal |
CN114133982A (en) * | 2021-11-23 | 2022-03-04 | 万华化学集团股份有限公司 | A method for preparing perfume with rose fragrance and raw material of composition |
CN115124413A (en) * | 2022-02-18 | 2022-09-30 | 山东新和成药业有限公司 | Method for preparing hydroxycitronellal from hydroxycitronellal |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1112563A (en) * | 1994-02-12 | 1995-11-29 | 弗·哈夫曼-拉罗切有限公司 | Water Soluble Phosphine Derivatives |
CN1579627A (en) * | 2003-08-05 | 2005-02-16 | 中国科学院大连化学物理研究所 | Chiral ligand metal complex catalyst system, and its preparation method and use |
CN101775035A (en) * | 2009-12-25 | 2010-07-14 | 青岛科技大学 | Synthesis of class of amino acid type amphoteric water-soluble chiral phosphine ligand and application thereof in asymmetric catalytic hydrogenation |
CN102458659A (en) * | 2009-06-03 | 2012-05-16 | 高砂香料工业株式会社 | Asymmetric hydrogenation catalyst |
CN105254474A (en) * | 2015-10-20 | 2016-01-20 | 万华化学集团股份有限公司 | Method for preparing chiral citronellol through asymmetric catalytic hydrogenation of citral |
CN105330515A (en) * | 2015-10-20 | 2016-02-17 | 万华化学集团股份有限公司 | Preparation method for optically-pure citronellol |
CN109071578A (en) * | 2016-05-06 | 2018-12-21 | 巴斯夫欧洲公司 | P- chiral phosphine ligand and its purposes for asymmetric syntheses |
-
2019
- 2019-12-05 CN CN201911237004.0A patent/CN110963902B/en active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1112563A (en) * | 1994-02-12 | 1995-11-29 | 弗·哈夫曼-拉罗切有限公司 | Water Soluble Phosphine Derivatives |
CN1579627A (en) * | 2003-08-05 | 2005-02-16 | 中国科学院大连化学物理研究所 | Chiral ligand metal complex catalyst system, and its preparation method and use |
CN102458659A (en) * | 2009-06-03 | 2012-05-16 | 高砂香料工业株式会社 | Asymmetric hydrogenation catalyst |
CN101775035A (en) * | 2009-12-25 | 2010-07-14 | 青岛科技大学 | Synthesis of class of amino acid type amphoteric water-soluble chiral phosphine ligand and application thereof in asymmetric catalytic hydrogenation |
CN105254474A (en) * | 2015-10-20 | 2016-01-20 | 万华化学集团股份有限公司 | Method for preparing chiral citronellol through asymmetric catalytic hydrogenation of citral |
CN105330515A (en) * | 2015-10-20 | 2016-02-17 | 万华化学集团股份有限公司 | Preparation method for optically-pure citronellol |
CN109071578A (en) * | 2016-05-06 | 2018-12-21 | 巴斯夫欧洲公司 | P- chiral phosphine ligand and its purposes for asymmetric syntheses |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111718250A (en) * | 2020-06-28 | 2020-09-29 | 万华化学集团股份有限公司 | Method for preparing R-citronellal |
CN111718250B (en) * | 2020-06-28 | 2022-04-22 | 万华化学集团股份有限公司 | Method for preparing R-citronellal |
CN114133982A (en) * | 2021-11-23 | 2022-03-04 | 万华化学集团股份有限公司 | A method for preparing perfume with rose fragrance and raw material of composition |
CN114133982B (en) * | 2021-11-23 | 2024-02-27 | 万华化学集团股份有限公司 | Method for preparing perfume with rose fragrance and composition raw materials |
CN115124413A (en) * | 2022-02-18 | 2022-09-30 | 山东新和成药业有限公司 | Method for preparing hydroxycitronellal from hydroxycitronellal |
CN115124413B (en) * | 2022-02-18 | 2023-11-28 | 山东新和成药业有限公司 | Method for preparing hydroxycitronellal from hydroxycitronellol |
Also Published As
Publication number | Publication date |
---|---|
CN110963902B (en) | 2023-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wu et al. | Synergistic Pd/Cu catalysis in organic synthesis | |
EP0718265B1 (en) | Method for producing an alcohol | |
Imlinger et al. | Arylation of Carbonyl Compounds Catalyzed by Rhodium and Iridium 1, 3‐R2‐Tetrahydropyrimidin‐2‐ylidenes: Structure‐Reactivity Correlations | |
CN110963902B (en) | Method for synthesizing R-citronellal by water-oil two-phase asymmetric hydrogenation and catalyst used in method | |
CN100584460C (en) | Asymmetric (transfer) hydrogenation catalysts | |
CN106458824B (en) | Method for preparing unsaturated carboxylic acid salt using aryl oxide | |
CN106458823B (en) | Process for preparing unsaturated carboxylic acid salts | |
CN110981707B (en) | Method for synthesizing chiral citronellal by isomerism of nerol or geraniol | |
JPH11189600A (en) | Ruthenium complex and method for producing alcohol compound using the same as catalyst | |
US8716507B2 (en) | Iron(II) catalysts containing diimino-diphosphine tetradentate ligands and their synthesis | |
CN108083980B (en) | Method for preparing optically pure L-menthol | |
EP2279992A1 (en) | Aluminum complex and use thereof | |
CN105330515B (en) | A kind of preparation method of optical voidness citronellol | |
JP2017508747A (en) | Ruthenium-phenol catalyst for hydrogen transfer reaction | |
US20070265448A1 (en) | Ruthenium Complex and Process for Producing Tert-Alkyl Alcohol Therewith | |
JP2731377B2 (en) | Method for producing optically active alcohols | |
CN109851486B (en) | Method for selectively hydrogenating dienone by ruthenium complex | |
Hanson | Catalytic Pauson Khand and related cycloaddition reactions | |
Gonsalvi et al. | Lower-and upper-rim-modified derivatives of 1, 3, 5-triaza-7-phosphaadamantane: Coordination chemistry and applications in catalytic reactions in water | |
WO2005092825A1 (en) | Process for production of optically active alcohols | |
Al-Shboul et al. | Catalytic synthesis of vinylphosphanes via calcium-mediated intermolecular hydrophosphanylation of alkynes and butadiynes | |
CN106607092A (en) | Catalyst composition and use thereof | |
CN108779042B (en) | Monocarbonyl Ruthenium and Osmium Catalysts | |
Faller et al. | Resolution of BIPHEP on Rh with a chiral diene auxiliary | |
CN106905124B (en) | Method for preparing optically active aldehyde or ketone |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |